CopyMark Law Group
4.9/5
Drawing for KIRIN PHARMA

USPTO serial 77062473

KIRIN PHARMA

Reviewed by CopyMark Law Group

Reg. 3474565Status 710
Filing date
Status date
Registration date
Jul 29, 2008
Examiner
HUGHITT, ELIZABETH
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with KIRIN PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Susan Upton Douglass

Goods and services

ClassDescriptionStatusFirst use
001(Based on 44e) biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; chemical reagents for non-medical and non-veterinary purposesSECTION 8 - CANCELLED—
005(Based on 44e) pharmaceutical preparations for the treatment of anemia, leukopenia, thrombocytopenia, hyperphosphatemia, hyperparathyroidism, cancer, leukemia, influenza, HIV, myelodysplastic syndrome, infectious diseases, autoimmune diseases; pharmaceutical preparations for mobilization of peripheral blood progenitor cells; pharmaceutical preparations for conditioning treatment prior to hematopoietic stem cell transplantation; diagnostic agents, preparations and substances for medical and veterinary use; pre-filled syringes filled with pharmaceutical preparations for the treatment of anemia, leucopenia, thrombocytopenia, mobilization of peripheral blood progenitor cell, hyperphosphatemia, hyperparathyroidism, cancer, leukemia, influenza, HIV, myelodysplastic syndrome, infectious diseases and autoimmune diseases, and for conditioning treatment prior to hematopoietic stem cell transplantationSECTION 8 - CANCELLED—
010(Based on 44e) syringes for medical purposes; injection devices for pharmaceuticals; injection needles; blood transfusion apparatus or devices; infusion apparatus or devices for therapeutic purposesSECTION 8 - CANCELLED—
042(Based on Use in Commerce) patent licensing; development of new technology for others in the field of human antibodies and biotechnology; medical researchSECTION 8 - CANCELLEDJul 1, 2007

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 6, 2015C8..CANCELLED SEC. 8 (6-YR)—
Feb 13, 2013ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 29, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 13, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 23, 2008NPUBNOTICE OF PUBLICATION—
Apr 9, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 8, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 8, 2008IUAAUSE AMENDMENT ACCEPTED—
Apr 8, 2008XAECEXAMINER'S AMENDMENT ENTERED—
Apr 8, 2008AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Apr 3, 2008GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 3, 2008GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 3, 2008CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 2, 2008ACECAMENDMENT FROM APPLICANT ENTERED—
Apr 2, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 2, 2008ALIEASSIGNED TO LIE—
Mar 27, 2008IUAFUSE AMENDMENT FILED—
Mar 27, 2008MAILPAPER RECEIVED—
Nov 28, 2007ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 9, 2007GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 9, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 9, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 19, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 19, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 19, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 6, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 6, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 5, 2007DOCKASSIGNED TO EXAMINER—
Dec 19, 2006MDSCNOTICE OF DESIGN SEARCH CODE MAILED—
Dec 18, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance